nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Clobetasol propionate—psoriasis	0.139	0.225	CbGbCtD
Rotigotine—CYP1A2—Methoxsalen—psoriasis	0.0731	0.118	CbGbCtD
Rotigotine—CYP2D6—Hydroxyurea—psoriasis	0.0658	0.106	CbGbCtD
Rotigotine—CYP3A4—Calcitriol—psoriasis	0.0492	0.0796	CbGbCtD
Rotigotine—CYP2D6—Cholecalciferol—psoriasis	0.0399	0.0645	CbGbCtD
Rotigotine—CYP3A4—Methoxsalen—psoriasis	0.0383	0.0619	CbGbCtD
Rotigotine—CYP2D6—Cyclosporine—psoriasis	0.0262	0.0424	CbGbCtD
Rotigotine—CYP3A4—Cholecalciferol—psoriasis	0.0254	0.041	CbGbCtD
Rotigotine—CYP3A4—Mycophenolate mofetil—psoriasis	0.022	0.0356	CbGbCtD
Rotigotine—CYP3A4—Triamcinolone—psoriasis	0.022	0.0356	CbGbCtD
Rotigotine—CYP3A4—Betamethasone—psoriasis	0.0189	0.0305	CbGbCtD
Rotigotine—CYP3A4—Prednisolone—psoriasis	0.0186	0.0301	CbGbCtD
Rotigotine—CYP3A4—Hydrocortisone—psoriasis	0.0176	0.0285	CbGbCtD
Rotigotine—CYP3A4—Prednisone—psoriasis	0.0176	0.0284	CbGbCtD
Rotigotine—CYP2D6—Dexamethasone—psoriasis	0.0173	0.0279	CbGbCtD
Rotigotine—CYP3A4—Cyclosporine—psoriasis	0.0167	0.0269	CbGbCtD
Rotigotine—CYP3A4—Dexamethasone—psoriasis	0.011	0.0177	CbGbCtD
Rotigotine—Infestation NOS—Methotrexate—psoriasis	0.000254	0.000681	CcSEcCtD
Rotigotine—Infestation—Methotrexate—psoriasis	0.000254	0.000681	CcSEcCtD
Rotigotine—Depression—Methotrexate—psoriasis	0.000253	0.000679	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000253	0.000678	CcSEcCtD
Rotigotine—Skin disorder—Hydrocortisone—psoriasis	0.000253	0.000678	CcSEcCtD
Rotigotine—Ill-defined disorder—Betamethasone—psoriasis	0.000253	0.000678	CcSEcCtD
Rotigotine—Ill-defined disorder—Dexamethasone—psoriasis	0.000253	0.000678	CcSEcCtD
Rotigotine—Discomfort—Triamcinolone—psoriasis	0.000253	0.000678	CcSEcCtD
Rotigotine—Fatigue—Cyclosporine—psoriasis	0.000253	0.000677	CcSEcCtD
Rotigotine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000252	0.000675	CcSEcCtD
Rotigotine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000252	0.000675	CcSEcCtD
Rotigotine—Pain—Cyclosporine—psoriasis	0.000251	0.000672	CcSEcCtD
Rotigotine—Constipation—Cyclosporine—psoriasis	0.000251	0.000672	CcSEcCtD
Rotigotine—Dry mouth—Triamcinolone—psoriasis	0.00025	0.000671	CcSEcCtD
Rotigotine—Angioedema—Dexamethasone—psoriasis	0.000249	0.000668	CcSEcCtD
Rotigotine—Angioedema—Betamethasone—psoriasis	0.000249	0.000668	CcSEcCtD
Rotigotine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000249	0.000666	CcSEcCtD
Rotigotine—Anorexia—Hydrocortisone—psoriasis	0.000248	0.000666	CcSEcCtD
Rotigotine—Diarrhoea—Mycophenolic acid—psoriasis	0.000248	0.000665	CcSEcCtD
Rotigotine—Angiopathy—Prednisone—psoriasis	0.000248	0.000664	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000247	0.000662	CcSEcCtD
Rotigotine—Immune system disorder—Prednisone—psoriasis	0.000247	0.000661	CcSEcCtD
Rotigotine—Malaise—Dexamethasone—psoriasis	0.000246	0.000659	CcSEcCtD
Rotigotine—Malaise—Betamethasone—psoriasis	0.000246	0.000659	CcSEcCtD
Rotigotine—Vertigo—Dexamethasone—psoriasis	0.000245	0.000657	CcSEcCtD
Rotigotine—Vertigo—Betamethasone—psoriasis	0.000245	0.000657	CcSEcCtD
Rotigotine—Syncope—Dexamethasone—psoriasis	0.000245	0.000656	CcSEcCtD
Rotigotine—Syncope—Betamethasone—psoriasis	0.000245	0.000656	CcSEcCtD
Rotigotine—Constipation—Mycophenolate mofetil—psoriasis	0.000245	0.000655	CcSEcCtD
Rotigotine—Pain—Mycophenolate mofetil—psoriasis	0.000245	0.000655	CcSEcCtD
Rotigotine—Infection—Triamcinolone—psoriasis	0.000244	0.000653	CcSEcCtD
Rotigotine—Hypotension—Hydrocortisone—psoriasis	0.000244	0.000653	CcSEcCtD
Rotigotine—Feeling abnormal—Cyclosporine—psoriasis	0.000242	0.000648	CcSEcCtD
Rotigotine—Shock—Triamcinolone—psoriasis	0.000242	0.000647	CcSEcCtD
Rotigotine—Insomnia—Prednisolone—psoriasis	0.000241	0.000647	CcSEcCtD
Rotigotine—Loss of consciousness—Dexamethasone—psoriasis	0.00024	0.000643	CcSEcCtD
Rotigotine—Loss of consciousness—Betamethasone—psoriasis	0.00024	0.000643	CcSEcCtD
Rotigotine—Dizziness—Mycophenolic acid—psoriasis	0.00024	0.000642	CcSEcCtD
Rotigotine—Paraesthesia—Prednisolone—psoriasis	0.00024	0.000642	CcSEcCtD
Rotigotine—Mental disorder—Prednisone—psoriasis	0.000239	0.000641	CcSEcCtD
Rotigotine—Malnutrition—Prednisone—psoriasis	0.000238	0.000637	CcSEcCtD
Rotigotine—Erythema—Prednisone—psoriasis	0.000238	0.000637	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000238	0.000636	CcSEcCtD
Rotigotine—Hyperhidrosis—Triamcinolone—psoriasis	0.000237	0.000636	CcSEcCtD
Rotigotine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000236	0.000632	CcSEcCtD
Rotigotine—Insomnia—Hydrocortisone—psoriasis	0.000236	0.000632	CcSEcCtD
Rotigotine—Hypertension—Dexamethasone—psoriasis	0.000236	0.000631	CcSEcCtD
Rotigotine—Hypertension—Betamethasone—psoriasis	0.000236	0.000631	CcSEcCtD
Rotigotine—Paraesthesia—Hydrocortisone—psoriasis	0.000234	0.000627	CcSEcCtD
Rotigotine—Urticaria—Cyclosporine—psoriasis	0.000233	0.000624	CcSEcCtD
Rotigotine—Vomiting—Mycophenolic acid—psoriasis	0.000231	0.000618	CcSEcCtD
Rotigotine—Discomfort—Betamethasone—psoriasis	0.00023	0.000615	CcSEcCtD
Rotigotine—Discomfort—Dexamethasone—psoriasis	0.00023	0.000615	CcSEcCtD
Rotigotine—Dyspepsia—Hydrocortisone—psoriasis	0.000229	0.000615	CcSEcCtD
Rotigotine—Rash—Mycophenolic acid—psoriasis	0.000229	0.000612	CcSEcCtD
Rotigotine—Dermatitis—Mycophenolic acid—psoriasis	0.000228	0.000612	CcSEcCtD
Rotigotine—Pain—Prednisolone—psoriasis	0.000228	0.000611	CcSEcCtD
Rotigotine—Urticaria—Mycophenolate mofetil—psoriasis	0.000227	0.000609	CcSEcCtD
Rotigotine—Headache—Mycophenolic acid—psoriasis	0.000227	0.000608	CcSEcCtD
Rotigotine—Decreased appetite—Hydrocortisone—psoriasis	0.000227	0.000607	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000225	0.000603	CcSEcCtD
Rotigotine—Fatigue—Hydrocortisone—psoriasis	0.000225	0.000602	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000224	0.000599	CcSEcCtD
Rotigotine—Pain—Hydrocortisone—psoriasis	0.000223	0.000597	CcSEcCtD
Rotigotine—Insomnia—Triamcinolone—psoriasis	0.000222	0.000595	CcSEcCtD
Rotigotine—Infection—Dexamethasone—psoriasis	0.000221	0.000593	CcSEcCtD
Rotigotine—Infection—Betamethasone—psoriasis	0.000221	0.000593	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisone—psoriasis	0.000221	0.000591	CcSEcCtD
Rotigotine—Paraesthesia—Triamcinolone—psoriasis	0.00022	0.00059	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisolone—psoriasis	0.00022	0.000589	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—psoriasis	0.00022	0.000589	CcSEcCtD
Rotigotine—Shock—Dexamethasone—psoriasis	0.000219	0.000587	CcSEcCtD
Rotigotine—Shock—Betamethasone—psoriasis	0.000219	0.000587	CcSEcCtD
Rotigotine—Nervous system disorder—Dexamethasone—psoriasis	0.000218	0.000585	CcSEcCtD
Rotigotine—Nervous system disorder—Betamethasone—psoriasis	0.000218	0.000585	CcSEcCtD
Rotigotine—Agitation—Prednisone—psoriasis	0.000218	0.000585	CcSEcCtD
Rotigotine—Angioedema—Prednisone—psoriasis	0.000217	0.000582	CcSEcCtD
Rotigotine—Hypersensitivity—Cyclosporine—psoriasis	0.000216	0.000579	CcSEcCtD
Rotigotine—Dyspepsia—Triamcinolone—psoriasis	0.000216	0.000579	CcSEcCtD
Rotigotine—Nausea—Mycophenolic acid—psoriasis	0.000215	0.000577	CcSEcCtD
Rotigotine—Hyperhidrosis—Betamethasone—psoriasis	0.000215	0.000577	CcSEcCtD
Rotigotine—Hyperhidrosis—Dexamethasone—psoriasis	0.000215	0.000577	CcSEcCtD
Rotigotine—Feeling abnormal—Hydrocortisone—psoriasis	0.000215	0.000575	CcSEcCtD
Rotigotine—Malaise—Prednisone—psoriasis	0.000214	0.000574	CcSEcCtD
Rotigotine—Vertigo—Prednisone—psoriasis	0.000214	0.000572	CcSEcCtD
Rotigotine—Syncope—Prednisone—psoriasis	0.000213	0.000571	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—psoriasis	0.000213	0.00057	CcSEcCtD
Rotigotine—Anorexia—Betamethasone—psoriasis	0.000212	0.000569	CcSEcCtD
Rotigotine—Anorexia—Dexamethasone—psoriasis	0.000212	0.000569	CcSEcCtD
Rotigotine—Urticaria—Prednisolone—psoriasis	0.000212	0.000568	CcSEcCtD
Rotigotine—Fatigue—Triamcinolone—psoriasis	0.000212	0.000567	CcSEcCtD
Rotigotine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000211	0.000565	CcSEcCtD
Rotigotine—Asthenia—Cyclosporine—psoriasis	0.00021	0.000564	CcSEcCtD
Rotigotine—Pain—Triamcinolone—psoriasis	0.00021	0.000562	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisone—psoriasis	0.000209	0.00056	CcSEcCtD
Rotigotine—Hypotension—Betamethasone—psoriasis	0.000208	0.000558	CcSEcCtD
Rotigotine—Hypotension—Dexamethasone—psoriasis	0.000208	0.000558	CcSEcCtD
Rotigotine—Pruritus—Cyclosporine—psoriasis	0.000208	0.000556	CcSEcCtD
Rotigotine—Urticaria—Hydrocortisone—psoriasis	0.000207	0.000555	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—psoriasis	0.000207	0.000555	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—psoriasis	0.000206	0.000552	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—psoriasis	0.000206	0.000551	CcSEcCtD
Rotigotine—Asthenia—Mycophenolate mofetil—psoriasis	0.000205	0.00055	CcSEcCtD
Rotigotine—Hypertension—Prednisone—psoriasis	0.000205	0.00055	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000203	0.000544	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000203	0.000544	CcSEcCtD
Rotigotine—Pruritus—Mycophenolate mofetil—psoriasis	0.000202	0.000542	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—psoriasis	0.000202	0.000542	CcSEcCtD
Rotigotine—Feeling abnormal—Triamcinolone—psoriasis	0.000202	0.000542	CcSEcCtD
Rotigotine—Insomnia—Dexamethasone—psoriasis	0.000201	0.00054	CcSEcCtD
Rotigotine—Insomnia—Betamethasone—psoriasis	0.000201	0.00054	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000201	0.000538	CcSEcCtD
Rotigotine—Diarrhoea—Cyclosporine—psoriasis	0.000201	0.000538	CcSEcCtD
Rotigotine—Paraesthesia—Betamethasone—psoriasis	0.0002	0.000536	CcSEcCtD
Rotigotine—Paraesthesia—Dexamethasone—psoriasis	0.0002	0.000536	CcSEcCtD
Rotigotine—Discomfort—Prednisone—psoriasis	0.0002	0.000536	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—psoriasis	0.0002	0.000535	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—psoriasis	0.000199	0.000532	CcSEcCtD
Rotigotine—Erythema—Methotrexate—psoriasis	0.000199	0.000532	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisolone—psoriasis	0.000197	0.000527	CcSEcCtD
Rotigotine—Dyspepsia—Dexamethasone—psoriasis	0.000196	0.000525	CcSEcCtD
Rotigotine—Dyspepsia—Betamethasone—psoriasis	0.000196	0.000525	CcSEcCtD
Rotigotine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000196	0.000524	CcSEcCtD
Rotigotine—Urticaria—Triamcinolone—psoriasis	0.000195	0.000522	CcSEcCtD
Rotigotine—Dizziness—Cyclosporine—psoriasis	0.000194	0.00052	CcSEcCtD
Rotigotine—Decreased appetite—Betamethasone—psoriasis	0.000194	0.000519	CcSEcCtD
Rotigotine—Decreased appetite—Dexamethasone—psoriasis	0.000194	0.000519	CcSEcCtD
Rotigotine—Infection—Prednisone—psoriasis	0.000193	0.000516	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000192	0.000515	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000192	0.000515	CcSEcCtD
Rotigotine—Hypersensitivity—Hydrocortisone—psoriasis	0.000192	0.000515	CcSEcCtD
Rotigotine—Fatigue—Dexamethasone—psoriasis	0.000192	0.000514	CcSEcCtD
Rotigotine—Fatigue—Betamethasone—psoriasis	0.000192	0.000514	CcSEcCtD
Rotigotine—Shock—Prednisone—psoriasis	0.000191	0.000511	CcSEcCtD
Rotigotine—Pain—Dexamethasone—psoriasis	0.00019	0.00051	CcSEcCtD
Rotigotine—Pain—Betamethasone—psoriasis	0.00019	0.00051	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—psoriasis	0.00019	0.00051	CcSEcCtD
Rotigotine—Dizziness—Mycophenolate mofetil—psoriasis	0.000189	0.000507	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—psoriasis	0.000188	0.000505	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisone—psoriasis	0.000188	0.000502	CcSEcCtD
Rotigotine—Asthenia—Hydrocortisone—psoriasis	0.000187	0.000501	CcSEcCtD
Rotigotine—Vomiting—Cyclosporine—psoriasis	0.000187	0.0005	CcSEcCtD
Rotigotine—Rash—Cyclosporine—psoriasis	0.000185	0.000495	CcSEcCtD
Rotigotine—Anorexia—Prednisone—psoriasis	0.000185	0.000495	CcSEcCtD
Rotigotine—Dermatitis—Cyclosporine—psoriasis	0.000185	0.000495	CcSEcCtD
Rotigotine—Pruritus—Hydrocortisone—psoriasis	0.000184	0.000494	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—psoriasis	0.000184	0.000494	CcSEcCtD
Rotigotine—Headache—Cyclosporine—psoriasis	0.000184	0.000492	CcSEcCtD
Rotigotine—Feeling abnormal—Dexamethasone—psoriasis	0.000184	0.000492	CcSEcCtD
Rotigotine—Feeling abnormal—Betamethasone—psoriasis	0.000184	0.000492	CcSEcCtD
Rotigotine—Vomiting—Mycophenolate mofetil—psoriasis	0.000182	0.000487	CcSEcCtD
Rotigotine—Hypersensitivity—Triamcinolone—psoriasis	0.000181	0.000484	CcSEcCtD
Rotigotine—Rash—Mycophenolate mofetil—psoriasis	0.00018	0.000483	CcSEcCtD
Rotigotine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00018	0.000483	CcSEcCtD
Rotigotine—Headache—Mycophenolate mofetil—psoriasis	0.000179	0.00048	CcSEcCtD
Rotigotine—Malaise—Methotrexate—psoriasis	0.000179	0.00048	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—psoriasis	0.000178	0.000478	CcSEcCtD
Rotigotine—Diarrhoea—Hydrocortisone—psoriasis	0.000178	0.000478	CcSEcCtD
Rotigotine—Urticaria—Betamethasone—psoriasis	0.000177	0.000474	CcSEcCtD
Rotigotine—Urticaria—Dexamethasone—psoriasis	0.000177	0.000474	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000177	0.000473	CcSEcCtD
Rotigotine—Dizziness—Prednisolone—psoriasis	0.000177	0.000473	CcSEcCtD
Rotigotine—Asthenia—Triamcinolone—psoriasis	0.000176	0.000472	CcSEcCtD
Rotigotine—Insomnia—Prednisone—psoriasis	0.000175	0.00047	CcSEcCtD
Rotigotine—Nausea—Cyclosporine—psoriasis	0.000174	0.000467	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—psoriasis	0.000174	0.000467	CcSEcCtD
Rotigotine—Pruritus—Triamcinolone—psoriasis	0.000174	0.000465	CcSEcCtD
Rotigotine—Cough—Methotrexate—psoriasis	0.000173	0.000464	CcSEcCtD
Rotigotine—Dizziness—Hydrocortisone—psoriasis	0.000172	0.000462	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—psoriasis	0.000171	0.000457	CcSEcCtD
Rotigotine—Nausea—Mycophenolate mofetil—psoriasis	0.00017	0.000455	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—psoriasis	0.000169	0.000453	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—psoriasis	0.000169	0.000452	CcSEcCtD
Rotigotine—Rash—Prednisolone—psoriasis	0.000168	0.000451	CcSEcCtD
Rotigotine—Dermatitis—Prednisolone—psoriasis	0.000168	0.00045	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000168	0.00045	CcSEcCtD
Rotigotine—Fatigue—Prednisone—psoriasis	0.000167	0.000448	CcSEcCtD
Rotigotine—Headache—Prednisolone—psoriasis	0.000167	0.000448	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—psoriasis	0.000167	0.000448	CcSEcCtD
Rotigotine—Constipation—Prednisone—psoriasis	0.000166	0.000444	CcSEcCtD
Rotigotine—Vomiting—Hydrocortisone—psoriasis	0.000166	0.000444	CcSEcCtD
Rotigotine—Rash—Hydrocortisone—psoriasis	0.000164	0.00044	CcSEcCtD
Rotigotine—Dermatitis—Hydrocortisone—psoriasis	0.000164	0.00044	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—psoriasis	0.000163	0.000438	CcSEcCtD
Rotigotine—Headache—Hydrocortisone—psoriasis	0.000163	0.000437	CcSEcCtD
Rotigotine—Dizziness—Triamcinolone—psoriasis	0.000162	0.000435	CcSEcCtD
Rotigotine—Infection—Methotrexate—psoriasis	0.000161	0.000431	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—psoriasis	0.00016	0.000428	CcSEcCtD
Rotigotine—Asthenia—Dexamethasone—psoriasis	0.00016	0.000428	CcSEcCtD
Rotigotine—Asthenia—Betamethasone—psoriasis	0.00016	0.000428	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—psoriasis	0.000159	0.000426	CcSEcCtD
Rotigotine—Nausea—Prednisolone—psoriasis	0.000159	0.000425	CcSEcCtD
Rotigotine—Pruritus—Betamethasone—psoriasis	0.000158	0.000422	CcSEcCtD
Rotigotine—Pruritus—Dexamethasone—psoriasis	0.000158	0.000422	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—psoriasis	0.000157	0.000422	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—psoriasis	0.000157	0.00042	CcSEcCtD
Rotigotine—Vomiting—Triamcinolone—psoriasis	0.000156	0.000418	CcSEcCtD
Rotigotine—Nausea—Hydrocortisone—psoriasis	0.000155	0.000415	CcSEcCtD
Rotigotine—Rash—Triamcinolone—psoriasis	0.000155	0.000415	CcSEcCtD
Rotigotine—Dermatitis—Triamcinolone—psoriasis	0.000155	0.000414	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—psoriasis	0.000155	0.000414	CcSEcCtD
Rotigotine—Urticaria—Prednisone—psoriasis	0.000154	0.000413	CcSEcCtD
Rotigotine—Headache—Triamcinolone—psoriasis	0.000154	0.000412	CcSEcCtD
Rotigotine—Diarrhoea—Dexamethasone—psoriasis	0.000152	0.000408	CcSEcCtD
Rotigotine—Diarrhoea—Betamethasone—psoriasis	0.000152	0.000408	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—psoriasis	0.000151	0.000406	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000148	0.000396	CcSEcCtD
Rotigotine—Dizziness—Dexamethasone—psoriasis	0.000147	0.000395	CcSEcCtD
Rotigotine—Dizziness—Betamethasone—psoriasis	0.000147	0.000395	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—psoriasis	0.000147	0.000393	CcSEcCtD
Rotigotine—Nausea—Triamcinolone—psoriasis	0.000146	0.000391	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—psoriasis	0.000146	0.00039	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—psoriasis	0.000144	0.000386	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—psoriasis	0.000143	0.000383	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—psoriasis	0.000143	0.000382	CcSEcCtD
Rotigotine—Vomiting—Dexamethasone—psoriasis	0.000142	0.000379	CcSEcCtD
Rotigotine—Vomiting—Betamethasone—psoriasis	0.000142	0.000379	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—psoriasis	0.000141	0.000377	CcSEcCtD
Rotigotine—Rash—Dexamethasone—psoriasis	0.00014	0.000376	CcSEcCtD
Rotigotine—Rash—Betamethasone—psoriasis	0.00014	0.000376	CcSEcCtD
Rotigotine—Dermatitis—Dexamethasone—psoriasis	0.00014	0.000376	CcSEcCtD
Rotigotine—Dermatitis—Betamethasone—psoriasis	0.00014	0.000376	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—psoriasis	0.00014	0.000375	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—psoriasis	0.00014	0.000374	CcSEcCtD
Rotigotine—Headache—Dexamethasone—psoriasis	0.00014	0.000374	CcSEcCtD
Rotigotine—Headache—Betamethasone—psoriasis	0.00014	0.000374	CcSEcCtD
Rotigotine—Asthenia—Prednisone—psoriasis	0.000139	0.000373	CcSEcCtD
Rotigotine—Pain—Methotrexate—psoriasis	0.000139	0.000371	CcSEcCtD
Rotigotine—Pruritus—Prednisone—psoriasis	0.000137	0.000368	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—psoriasis	0.000134	0.000358	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—psoriasis	0.000133	0.000356	CcSEcCtD
Rotigotine—Nausea—Dexamethasone—psoriasis	0.000132	0.000354	CcSEcCtD
Rotigotine—Nausea—Betamethasone—psoriasis	0.000132	0.000354	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—psoriasis	0.000129	0.000345	CcSEcCtD
Rotigotine—Dizziness—Prednisone—psoriasis	0.000128	0.000344	CcSEcCtD
Rotigotine—Vomiting—Prednisone—psoriasis	0.000123	0.00033	CcSEcCtD
Rotigotine—Rash—Prednisone—psoriasis	0.000122	0.000328	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—psoriasis	0.000122	0.000327	CcSEcCtD
Rotigotine—Headache—Prednisone—psoriasis	0.000122	0.000326	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—psoriasis	0.000119	0.00032	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—psoriasis	0.000116	0.000312	CcSEcCtD
Rotigotine—Nausea—Prednisone—psoriasis	0.000115	0.000309	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—psoriasis	0.000115	0.000307	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—psoriasis	0.000111	0.000297	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—psoriasis	0.000107	0.000287	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—psoriasis	0.000103	0.000276	CcSEcCtD
Rotigotine—Rash—Methotrexate—psoriasis	0.000102	0.000274	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—psoriasis	0.000102	0.000274	CcSEcCtD
Rotigotine—Headache—Methotrexate—psoriasis	0.000102	0.000272	CcSEcCtD
Rotigotine—Nausea—Methotrexate—psoriasis	9.63e-05	0.000258	CcSEcCtD
Rotigotine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.41e-05	0.00419	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.37e-05	0.00414	CbGpPWpGaD
Rotigotine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.29e-05	0.00404	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—CCL20—psoriasis	3.21e-05	0.00395	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	3.18e-05	0.00391	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HCAR2—psoriasis	3.17e-05	0.0039	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—CCL20—psoriasis	3.17e-05	0.00389	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HCAR2—psoriasis	3.13e-05	0.00385	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—IL10—psoriasis	3.13e-05	0.00384	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HCAR2—psoriasis	3.11e-05	0.00382	CbGpPWpGaD
Rotigotine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.01e-05	0.0037	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HCAR2—psoriasis	3e-05	0.00369	CbGpPWpGaD
Rotigotine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.94e-05	0.00362	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—CCL20—psoriasis	2.86e-05	0.00352	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HCAR2—psoriasis	2.83e-05	0.00347	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HCAR2—psoriasis	2.82e-05	0.00347	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—CCL20—psoriasis	2.76e-05	0.00339	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—CCL20—psoriasis	2.73e-05	0.00336	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HCAR2—psoriasis	2.73e-05	0.00335	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—LEP—psoriasis	2.71e-05	0.00333	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HCAR2—psoriasis	2.64e-05	0.00324	CbGpPWpGaD
Rotigotine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	2.55e-05	0.00313	CbGpPWpGaD
Rotigotine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.54e-05	0.00312	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—NOS2—psoriasis	2.53e-05	0.00311	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—CCL20—psoriasis	2.48e-05	0.00305	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TAGAP—psoriasis	2.45e-05	0.00301	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—LEP—psoriasis	2.44e-05	0.003	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—CCL20—psoriasis	2.42e-05	0.00298	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—LEP—psoriasis	2.41e-05	0.00296	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HCAR2—psoriasis	2.4e-05	0.00294	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—PPARG—psoriasis	2.36e-05	0.0029	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—ITGAL—psoriasis	2.36e-05	0.0029	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—NOS2—psoriasis	2.28e-05	0.0028	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—NOS2—psoriasis	2.25e-05	0.00276	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—PPARG—psoriasis	2.13e-05	0.00261	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.12e-05	0.0026	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—PPARG—psoriasis	2.1e-05	0.00258	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HCAR2—psoriasis	2.08e-05	0.00256	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—CCL20—psoriasis	2.02e-05	0.00248	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HCAR2—psoriasis	1.87e-05	0.0023	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HCAR2—psoriasis	1.85e-05	0.00227	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—LEP—psoriasis	1.84e-05	0.00227	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.83e-05	0.00225	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CCL20—psoriasis	1.83e-05	0.00225	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—CCL20—psoriasis	1.81e-05	0.00223	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TAGAP—psoriasis	1.8e-05	0.00222	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—CCL20—psoriasis	1.79e-05	0.0022	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.76e-05	0.00217	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—NOS2—psoriasis	1.72e-05	0.00211	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.71e-05	0.00211	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.71e-05	0.0021	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—JUN—psoriasis	1.68e-05	0.00206	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HCAR2—psoriasis	1.67e-05	0.00205	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CCL20—psoriasis	1.65e-05	0.00203	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CCL20—psoriasis	1.63e-05	0.002	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TAGAP—psoriasis	1.62e-05	0.002	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CCL20—psoriasis	1.62e-05	0.00199	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HCAR2—psoriasis	1.61e-05	0.00198	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—PPARG—psoriasis	1.61e-05	0.00197	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TAGAP—psoriasis	1.6e-05	0.00197	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.6e-05	0.00197	CbGpPWpGaD
Rotigotine—DRD4—G alpha (i) signalling events—CXCL8—psoriasis	1.59e-05	0.00195	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	1.59e-05	0.00195	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CCL20—psoriasis	1.56e-05	0.00192	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.53e-05	0.00188	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—JUN—psoriasis	1.51e-05	0.00185	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—JUN—psoriasis	1.49e-05	0.00183	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CCL20—psoriasis	1.47e-05	0.0018	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CCL20—psoriasis	1.46e-05	0.0018	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TAGAP—psoriasis	1.45e-05	0.00178	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CCL20—psoriasis	1.42e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HCAR2—psoriasis	1.41e-05	0.00174	CbGpPWpGaD
Rotigotine—DRD3—G alpha (i) signalling events—CXCL8—psoriasis	1.41e-05	0.00174	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TAGAP—psoriasis	1.4e-05	0.00172	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.39e-05	0.00171	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.37e-05	0.00169	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.37e-05	0.00169	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CCL20—psoriasis	1.37e-05	0.00168	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—CXCL8—psoriasis	1.3e-05	0.0016	CbGpPWpGaD
Rotigotine—ADRA2B—G alpha (i) signalling events—CXCL8—psoriasis	1.28e-05	0.00157	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.26e-05	0.00155	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CCL20—psoriasis	1.24e-05	0.00153	CbGpPWpGaD
Rotigotine—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	1.23e-05	0.00151	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TAGAP—psoriasis	1.23e-05	0.00151	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	1.19e-05	0.00146	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—JUN—psoriasis	1.14e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.14e-05	0.0014	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.12e-05	0.00138	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—psoriasis	1.11e-05	0.00136	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.09e-05	0.00134	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCL20—psoriasis	1.08e-05	0.00133	CbGpPWpGaD
Rotigotine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	1.08e-05	0.00133	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.05e-05	0.00129	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.01e-05	0.00125	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—IL6—psoriasis	1.01e-05	0.00124	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—TP53—psoriasis	9.96e-06	0.00122	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—psoriasis	9.83e-06	0.00121	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.79e-06	0.0012	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCL20—psoriasis	9.73e-06	0.0012	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—NOS2—psoriasis	9.68e-06	0.00119	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—CXCL8—psoriasis	9.63e-06	0.00118	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL20—psoriasis	9.6e-06	0.00118	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	9.6e-06	0.00118	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—IL6—psoriasis	9.12e-06	0.00112	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—IL6—psoriasis	8.99e-06	0.00111	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP2S1—psoriasis	8.93e-06	0.0011	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NDUFA5—psoriasis	8.89e-06	0.00109	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL20—psoriasis	8.67e-06	0.00107	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—CXCL8—psoriasis	8.67e-06	0.00107	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	8.6e-06	0.00106	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—CXCL8—psoriasis	8.56e-06	0.00105	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL20—psoriasis	8.37e-06	0.00103	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.29e-06	0.00102	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SOCS1—psoriasis	8.07e-06	0.000991	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—CXCL8—psoriasis	7.72e-06	0.000949	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—TYK2—psoriasis	7.69e-06	0.000945	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2S1—psoriasis	7.56e-06	0.000929	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—psoriasis	7.52e-06	0.000924	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—CXCL8—psoriasis	7.46e-06	0.000916	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—CXCL8—psoriasis	7.37e-06	0.000906	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL20—psoriasis	7.35e-06	0.000903	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—IL6—psoriasis	6.88e-06	0.000846	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NDUFA5—psoriasis	6.86e-06	0.000844	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—CXCL8—psoriasis	6.7e-06	0.000823	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—CXCL8—psoriasis	6.55e-06	0.000805	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SOCS1—psoriasis	5.95e-06	0.000732	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—LEP—psoriasis	5.95e-06	0.000732	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—APOE—psoriasis	5.95e-06	0.000732	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2S1—psoriasis	5.84e-06	0.000717	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—TYK2—psoriasis	5.68e-06	0.000698	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—VEGFA—psoriasis	5.61e-06	0.000689	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NFKBIA—psoriasis	5.55e-06	0.000682	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—CXCL8—psoriasis	5.44e-06	0.000669	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SOCS1—psoriasis	5.36e-06	0.000659	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SOCS1—psoriasis	5.29e-06	0.00065	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—TYK2—psoriasis	5.11e-06	0.000628	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—TYK2—psoriasis	5.04e-06	0.00062	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—CXCL8—psoriasis	4.94e-06	0.000607	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	4.9e-06	0.000602	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—CXCL8—psoriasis	4.83e-06	0.000594	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	4.77e-06	0.000587	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SOCS1—psoriasis	4.61e-06	0.000566	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	4.55e-06	0.000559	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TYK2—psoriasis	4.54e-06	0.000558	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—CXCL8—psoriasis	4.45e-06	0.000547	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—TYK2—psoriasis	4.39e-06	0.00054	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—LEP—psoriasis	4.39e-06	0.00054	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—APOE—psoriasis	4.39e-06	0.00054	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—CXCL8—psoriasis	4.39e-06	0.00054	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	4.36e-06	0.000536	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CARM1—psoriasis	4.36e-06	0.000536	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—psoriasis	4.24e-06	0.000521	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	4.21e-06	0.000518	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NFKBIA—psoriasis	4.09e-06	0.000503	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SOCS1—psoriasis	4.05e-06	0.000497	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	3.96e-06	0.000487	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.96e-06	0.000487	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CXCL8—psoriasis	3.96e-06	0.000486	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—LEP—psoriasis	3.96e-06	0.000486	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—APOE—psoriasis	3.96e-06	0.000486	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—LEP—psoriasis	3.9e-06	0.00048	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—APOE—psoriasis	3.9e-06	0.00048	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—TYK2—psoriasis	3.86e-06	0.000474	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	3.83e-06	0.00047	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—IL6—psoriasis	3.76e-06	0.000462	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	3.7e-06	0.000455	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CARM1—psoriasis	3.69e-06	0.000454	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NFKBIA—psoriasis	3.69e-06	0.000453	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—JUN—psoriasis	3.68e-06	0.000452	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NFKBIA—psoriasis	3.64e-06	0.000447	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NFKB1—psoriasis	3.54e-06	0.000435	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—LEP—psoriasis	3.52e-06	0.000433	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—APOE—psoriasis	3.52e-06	0.000433	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.45e-06	0.000424	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOE—psoriasis	3.4e-06	0.000418	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—LEP—psoriasis	3.4e-06	0.000418	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CXCL8—psoriasis	3.36e-06	0.000413	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TYK2—psoriasis	3.35e-06	0.000412	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	3.28e-06	0.000404	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—psoriasis	3.21e-06	0.000395	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—psoriasis	3.18e-06	0.000391	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	3.17e-06	0.00039	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TYK2—psoriasis	3.02e-06	0.000371	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—LEP—psoriasis	2.99e-06	0.000367	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—psoriasis	2.99e-06	0.000367	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TYK2—psoriasis	2.98e-06	0.000366	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CXCL8—psoriasis	2.92e-06	0.000359	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CARM1—psoriasis	2.85e-06	0.00035	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKBIA—psoriasis	2.78e-06	0.000342	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—IL6—psoriasis	2.78e-06	0.000341	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—JUN—psoriasis	2.71e-06	0.000334	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TYK2—psoriasis	2.69e-06	0.000331	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAT—psoriasis	2.68e-06	0.00033	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—psoriasis	2.63e-06	0.000323	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NFKB1—psoriasis	2.61e-06	0.000321	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TYK2—psoriasis	2.6e-06	0.000319	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—psoriasis	2.59e-06	0.000319	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—psoriasis	2.5e-06	0.000307	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—psoriasis	2.47e-06	0.000303	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—psoriasis	2.44e-06	0.0003	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—psoriasis	2.43e-06	0.000298	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—psoriasis	2.41e-06	0.000296	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—psoriasis	2.37e-06	0.000291	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NFKB1—psoriasis	2.35e-06	0.000289	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—psoriasis	2.35e-06	0.000289	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	2.34e-06	0.000288	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NFKB1—psoriasis	2.32e-06	0.000285	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TYK2—psoriasis	2.28e-06	0.00028	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAT—psoriasis	2.27e-06	0.000279	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—psoriasis	2.26e-06	0.000278	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—psoriasis	2.23e-06	0.000274	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—psoriasis	2.22e-06	0.000273	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—psoriasis	2.18e-06	0.000268	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—psoriasis	2.15e-06	0.000264	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—psoriasis	2.13e-06	0.000262	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—psoriasis	2.11e-06	0.00026	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—psoriasis	2.11e-06	0.000259	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—psoriasis	2.1e-06	0.000258	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	2.1e-06	0.000258	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—psoriasis	2.09e-06	0.000256	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—psoriasis	2.08e-06	0.000256	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKB1—psoriasis	2.02e-06	0.000249	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.98e-06	0.000244	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	1.9e-06	0.000234	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—psoriasis	1.89e-06	0.000232	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—psoriasis	1.88e-06	0.000231	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—psoriasis	1.84e-06	0.000227	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.84e-06	0.000226	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.82e-06	0.000223	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—psoriasis	1.81e-06	0.000223	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—psoriasis	1.79e-06	0.00022	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.78e-06	0.000218	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—psoriasis	1.76e-06	0.000217	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAT—psoriasis	1.75e-06	0.000215	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—psoriasis	1.64e-06	0.000202	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—psoriasis	1.61e-06	0.000198	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.61e-06	0.000198	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—psoriasis	1.6e-06	0.000196	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—psoriasis	1.59e-06	0.000196	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—psoriasis	1.54e-06	0.000189	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—psoriasis	1.48e-06	0.000181	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—psoriasis	1.46e-06	0.000179	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—psoriasis	1.44e-06	0.000177	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—psoriasis	1.39e-06	0.00017	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—psoriasis	1.36e-06	0.000167	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—psoriasis	1.32e-06	0.000162	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—psoriasis	1.27e-06	0.000156	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—psoriasis	1.22e-06	0.00015	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—psoriasis	1.19e-06	0.000146	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—psoriasis	1.11e-06	0.000137	CbGpPWpGaD
